Registration
FEROX STRATEGIES for FRESENIUS KABI USA LLC
Firm
Client
Income
—
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Policy and oversight related to generic and biosimilar industry issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CRISTINA ANTELO New | Legal Fellow, Senate Democratic Steering Committee. |
| MICHAEL TAGGART New | Energy and Commerce Committee --Policy Director; Rep. Cathy McMorris Rodgers -- Legislative Director; Rep. Leonard Lance-- Staff Assistant, Legislative Correspondent, Legislative Assistant, Senior Legislative Assistant, Legislative Director |
| MARK WILLIAMS New | Chief of Staff, Rep. Michael Conaway // Chief of Staff, Rep. Todd Rokita // Dep. Chief of Staff/Leg. Director, Rep. Sam Johnson. |
Pharmacy PHA
Policy and oversight related to generic and biosimilar industry issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CRISTINA ANTELO New | Legal Fellow, Senate Democratic Steering Committee. |
| MICHAEL TAGGART New | Energy and Commerce Committee --Policy Director; Rep. Cathy McMorris Rodgers -- Legislative Director; Rep. Leonard Lance-- Staff Assistant, Legislative Correspondent, Legislative Assistant, Senior Legislative Assistant, Legislative Director |
| MARK WILLIAMS New | Chief of Staff, Rep. Michael Conaway // Chief of Staff, Rep. Todd Rokita // Dep. Chief of Staff/Leg. Director, Rep. Sam Johnson. |
Foreign entities
Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.
| Entity | Country | Principal place of business | Ownership | Contribution declared |
|---|---|---|---|---|
| FRESENIUS KABI SWISSBIOSIM GMBH | Switzerland | Switzerland | 100.0% | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.